C4 Therapeutics Inc. PS Ratio 2020–2026

PE Ratio PS Ratio Price to Book Price to FCF Net Worth

Current and historical P/S ratio for C4 Therapeutics Inc. (CCCC): market cap divided by trailing twelve-month revenue. As of March 31, 2026 it is 10.67.

From: 06/30/2022To: 03/31/2026

Stock Price

TTM Revenue

PS Ratio

C4 Therapeutics Inc. PS Ratio — FAQ

C4 Therapeutics Inc. (CCCC) ps ratio over the last 5 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CCCC's ps ratio history?

The chart and table above show C4 Therapeutics Inc.'s ps ratio by year and by quarter, including the growth rate.